| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,264 |
21,356 |
$1.62M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,106 |
6,927 |
$722K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,708 |
6,508 |
$554K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,463 |
6,463 |
$550K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,338 |
9,336 |
$411K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,317 |
1,317 |
$105K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,501 |
1,489 |
$68K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,485 |
2,484 |
$41K |
| 99188 |
|
3,176 |
3,176 |
$31K |
| 92551 |
|
3,430 |
3,428 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,788 |
1,753 |
$26K |
| 87428 |
|
704 |
695 |
$20K |
| 96161 |
|
3,956 |
3,955 |
$19K |
| 96127 |
|
3,838 |
3,827 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
197 |
196 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
288 |
284 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
184 |
182 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
37 |
37 |
$4K |
| 99460 |
|
29 |
29 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
251 |
251 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
66 |
66 |
$2K |
| 90480 |
|
50 |
50 |
$2K |
| 87634 |
|
13 |
13 |
$811.72 |
| 0071A |
|
18 |
18 |
$659.92 |
| 88720 |
|
122 |
106 |
$536.40 |
| 0072A |
|
18 |
18 |
$520.00 |
| 99051 |
|
77 |
75 |
$519.75 |
| 85018 |
|
256 |
256 |
$478.97 |
| 96380 |
|
12 |
12 |
$236.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$14.30 |
| 90686 |
|
3,745 |
3,745 |
$2.46 |
| 90677 |
|
1,230 |
1,229 |
$0.28 |
| 90633 |
|
430 |
430 |
$0.02 |
| 90670 |
|
3,152 |
3,151 |
$0.00 |
| 96160 |
|
507 |
507 |
$0.00 |
| 90681 |
|
154 |
154 |
$0.00 |
| 90661 |
|
194 |
194 |
$0.00 |
| 90710 |
|
14 |
14 |
$0.00 |
| 90697 |
|
1,786 |
1,786 |
$0.00 |
| 90680 |
|
1,506 |
1,506 |
$0.00 |
| 90744 |
|
142 |
142 |
$0.00 |
| 90698 |
|
967 |
967 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |